These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11781074)

  • 1. Chronic exposure to carbon monoxide and nicotine: endothelin ET(A) receptor antagonism attenuates carbon monoxide-induced myocardial hypertrophy in rat.
    Loennechen JP; Nilsen OG; Arbo I; Aadahl P; Nilsen T; Waldum HL; Sandvik AK; Ellingsen O
    Toxicol Appl Pharmacol; 2002 Jan; 178(1):8-14. PubMed ID: 11781074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic carbon monoxide exposure in vivo induces myocardial endothelin-1 expression and hypertrophy in rat.
    Loennechen JP; Beisvag V; Arbo I; Waldum HL; Sandvik AK; Knardahl S; Ellingsen O
    Pharmacol Toxicol; 1999 Oct; 85(4):192-7. PubMed ID: 10563519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
    Ehmke H; Faulhaber J; Münter K; Kirchengast M; Wiesner RJ
    Hypertension; 1999 Apr; 33(4):954-60. PubMed ID: 10205230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-treated rats.
    Prié S; Leung TK; Cernacek P; Ryan JW; Dupuis J
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1312-8. PubMed ID: 9316840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
    Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
    Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
    Jasmin JF; Cernacek P; Dupuis J
    Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon monoxide-induced cardiac hypertrophy is not reduced by alpha- or beta-blockade in the rat.
    Penney DG; Formolo JM
    Toxicology; 1993 Jun; 80(2-3):173-87. PubMed ID: 8392228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominant activation of endothelin-dependent cardiac hypertrophy by norepinephrine in rat left ventricle.
    Moser L; Faulhaber J; Wiesner RJ; Ehmke H
    Am J Physiol Regul Integr Comp Physiol; 2002 May; 282(5):R1389-94. PubMed ID: 11959681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension.
    Bianciotti LG; de Bold AJ
    Cardiovasc Res; 2001 Mar; 49(4):808-16. PubMed ID: 11230980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat.
    Brunner F
    Cardiovasc Res; 1999 Oct; 44(1):197-206. PubMed ID: 10615403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
    Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
    Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
    Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
    J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for carbon monoxide as the major factor contributing to lower fetal weights in rats exposed to cigarette smoke.
    Carmines EL; Rajendran N
    Toxicol Sci; 2008 Apr; 102(2):383-91. PubMed ID: 18203688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomegaly in neonatal rats exposed to 500 ppm carbon monoxide.
    Clubb FJ; Penney DG; Bishop SP
    J Mol Cell Cardiol; 1989 Sep; 21(9):945-55. PubMed ID: 2530359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat.
    Nguyen QT; Cernacek P; Calderoni A; Stewart DJ; Picard P; Sirois P; White M; Rouleau JL
    Circulation; 1998 Nov; 98(21):2323-30. PubMed ID: 9826321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endothelin-1 on erythropoietin production in a rat model under normoxia and functional carbon monoxide-induced hypoxia.
    Grenz A; Klein J; Köhle C; Freudenthaler S; Proksch B; Wu J; Wolf S; Osswald H; Gleiter CH
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Aug; 373(5):342-8. PubMed ID: 16896802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
    Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
    Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the transient outward K+ current by inhibition of endothelin-A receptors in normal and hypertrophied rat hearts.
    Wagner M; Goltz D; Stucke C; Schwoerer AP; Ehmke H; Volk T
    Pflugers Arch; 2007 Jul; 454(4):595-604. PubMed ID: 17333248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1.
    Kiss O; Gellér L; Merkely B; Szabó T; Raschack M; Seres L; Zima E; Juhász-Nagy A; Horkay F
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S317-9. PubMed ID: 11078408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary vessel alterations following chronic carbon monoxide exposure in the adult rat.
    Penney DG; Giraldo AA; Van Egmond EM
    J Appl Toxicol; 1994; 14(1):47-54. PubMed ID: 8157870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.